International Alliance for Biological Standardization

Select Page

July 20, 2022
13:00 – 15:00 CEST

IABS is a non-for-profit organisation that brings together academia, authority regulators and industry to discuss challenging projects.

Next Generation Sequencing (NGS) is such a project. It is a new technique that might replace a number of time consuming and costly viral testing, and time consuming, to show the absence of adventitious agents.

In Washington, September 28-29, the 3rd IABS NGS meeting will take place to discuss the implementation of these new techniques in detecting adventitious agents in the production and development of new and old vaccines.

However, not everyone is familiar with NGS and therefore IABS together with DCVMN decided to organise a webinar to give an introduction on NGS, in fact to initiate people not aware of these new techniques in order to understand the topics being discussed at the September meeting to implement these money and time saving techniques.

This is an invitation for people working in the field of vaccine production and development that are not aware of these new techniques and want to learn more about it to improve the production and development of their vaccines.

This is a collaboration between IABS and DCMN to improve knowledge of new techniques.

Agenda
13:00-13:05 Welcome Pieter Neels – IABS
13:05-13:25

Introduction to NGS

Burning questions

Sebastiaan Theuns – PathoSense
13:30-13:50

EDQM achievements and perspectives on Next Generation Sequencing

Burning questions

Laurent Mallet – EDQM

Gwenael Cirefice – EDQM

12:55-14:15

Reference Materials for NGS

Burning questions

Arifa Khan – FDA
14:20-14:40 NGS at WHO/ECBS/NIBSC To be confirmed
14:40-15:00 Questions All
Speakers

Pieter Neels – IABS

Sebastiaan Theuns – PathoSense

Laurent Mallet – EDQM

Gwenael Cirefice – EDQM

Arifa Khan – FDA

WHO representative -To be confirmed